Back to results
US 8,409,637 B2Granted
Compositions and methods for treating and preventing migrainous headaches and associated symptoms
AssigneePuraMed BioScience Inc.
InventorsRussell W Mitchell, James W. Higgins
Life of this patent
Estimating the term…
Abstract
Compositions and methods of treating migrainous headaches and their associated symptoms are provided. Methods of treating migrainous headaches and their associated symptoms include administering a lipid-based composition containing feverfew extract and ginger extract sublingually to a patient in need thereof. Treatments are effective using low total administered amounts of feverfew and ginger extracts.
Claims8
A method of treating acute migrainous headaches, comprising:
- sublingually administering a non-aqueous, lipid-based composition in liquid form to a patient, the non-aqueous, lipid-based composition consisting essentially of:
- (1) a lipid having an oleic acid content of 70% or greater,
- (2) feverfew extract, and
- (3) ginger extract,
- wherein the non-aqueous, lipid-based composition has increased stability as compared with aqueous solutions, and delivery Of the non-aqueous, lipid-based composition in liquid form sublingually to a patient in need thereof provides rapid bodily absorption of the feverfew extract and the ginger extract to facilitate migraine relief,
- wherein the composition is delivered in one or more individual doses not exceeding about 30 mg of feverfew extract.
3 more elements
A method of acute treatment of migrainous headaches, comprising
- sublingually administering a non-aqueous, lipid-based composition in liquid form to allow rapid bodily absorption of the non-aqueous, lipid-based composition, the non-aqueous, lipid-based composition consisting essentially of
- (1) a lipid having an oleic acid content of 70% or greater,
- (2) feverfew extract and
- (3) ginger extract,
- wherein the non-aqueous, lipid-based composition has increased stability as compared with aqueous solutions, and delivery of the non-aqueous, lipid-based composition sublingually to a patient in need thereof in liquid form facilitates timely pain relief as compared to non-liquid, non-sublingual delivery methods,
- wherein the non-aqueous, lipid-based composition is delivered in two or more individual doses not exceeding about 30 mg of feverfew extract.
3 more elements
Dependencies are inferred from the claim text.